Open AccessSusceptibility to R-pyocins of Pseudomonas aeruginosa clinical isolates from cystic fibrosis patients
Author(s) -
Mar Redero Cascón,
Carla López-Causapé,
Javier Aznar,
Antonio Oliver,
Jesús Blázquez,
Ana I. Prieto
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky261
Subject(s) - pseudomonas aeruginosa , cystic fibrosis , medicine , microbiology and biotechnology , biology , bacteria , genetics
The appearance and dissemination of MDR among pathogenic bacteria has forced the search for new antimicrobials. Bacteriocins have been proposed as potential alternatives for the treatment of infections due to multiresistant strains.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom